These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27544573)

  • 1. Perfluoroalkyl substances and endometriosis in US women in NHANES 2003-2006.
    Campbell S; Raza M; Pollack AZ
    Reprod Toxicol; 2016 Oct; 65():230-235. PubMed ID: 27544573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: The influence of oral contraceptive use.
    Ngueta G; Longnecker MP; Yoon M; Ruark CD; Clewell HJ; Andersen ME; Verner MA
    Environ Int; 2017 Jul; 104():118-121. PubMed ID: 28392065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6-11 years.
    Jain RB; Ducatman A
    Environ Pollut; 2018 Dec; 243(Pt A):1-8. PubMed ID: 30170203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pregnancy on the levels of selected perfluoroalkyl compounds for females aged 17-39 years: data from National Health and Nutrition Examination Survey 2003-2008.
    Jain RB
    J Toxicol Environ Health A; 2013; 76(7):409-21. PubMed ID: 23611181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.
    Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J;
    Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins.
    Jain RB; Ducatman A
    Sci Total Environ; 2019 Feb; 653():74-81. PubMed ID: 30408670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study.
    Tanner EM; Bloom MS; Wu Q; Kannan K; Yucel RM; Shrestha S; Fitzgerald EF
    Int Arch Occup Environ Health; 2018 Feb; 91(2):145-154. PubMed ID: 29027000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.
    Melzer D; Rice N; Depledge MH; Henley WE; Galloway TS
    Environ Health Perspect; 2010 May; 118(5):686-92. PubMed ID: 20089479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of prenatal exposure to perfluoroalkyl substances in the Slovak birth cohort.
    Richterová D; Fábelová L; Patayová H; Pulkrabová J; Lanková D; Rausová K; Šovčíková E; Štencl J; Hajšlová J; Trnovec T; Palkovičová Murínová Ľ
    Environ Int; 2018 Dec; 121(Pt 2):1304-1310. PubMed ID: 30420127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between perfluoroalkyl acids and the prevalence of hypertension among US adults.
    Liao S; Yao W; Cheang I; Tang X; Yin T; Lu X; Zhou Y; Zhang H; Li X
    Ecotoxicol Environ Saf; 2020 Jun; 196():110589. PubMed ID: 32278136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
    Calafat AM; Wong LY; Kuklenyik Z; Reidy JA; Needham LL
    Environ Health Perspect; 2007 Nov; 115(11):1596-602. PubMed ID: 18007991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
    Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
    Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can profiles of poly- and Perfluoroalkyl substances (PFASs) in human serum provide information on major exposure sources?
    Hu XC; Dassuncao C; Zhang X; Grandjean P; Weihe P; Webster GM; Nielsen F; Sunderland EM
    Environ Health; 2018 Feb; 17(1):11. PubMed ID: 29391068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function: Implications for future research.
    Jain RB; Ducatman A
    Environ Res; 2019 Feb; 169():476-482. PubMed ID: 30530087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends over 2003-2014 in the concentrations of selected perfluoroalkyl substances among US adults aged ≥20 years: Interpretational issues.
    Jain RB
    Sci Total Environ; 2018 Dec; 645():946-957. PubMed ID: 30248883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.